A phase II pilot study of thalidomide with temozolomide in patients with relapsed or progressive brain tumors or neuroblastoma
Phase of Trial: Phase II
Latest Information Update: 11 Nov 2014
At a glance
- Drugs Thalidomide (Primary) ; Temozolomide
- Indications Brain cancer; Neuroblastoma
- Focus Adverse reactions
- 06 Jul 2011 Status changed from active, no longer recruiting to completed as repoted by ClinicalTrials.gov.
- 06 Jul 2011 Company added in the associarion field and additional lead trial center identified as reported by ClinicalTrials.gov.
- 06 Jul 2011 Actual end date is Dec 2010 as reported by ClinicalTrials.gov.